Video

Single administration of intracameral bimatoprost implant: IOP lowering, safety

Author(s):

David Hutton,Alex Delaney-Gesing
Conferences|AAO

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

Michael R. Robinson, MD, vice president, Global Therapeutic Area Head, Ophthalmology at Allergan, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

See more AAO coverage here

Related Videos
(Image credit: Ophthalmology Times) Thomas W. Samuelson, MD, shares clinical perspectives on DSLT, SLT, and glaucoma management
Related Content
Seonix Bio launches SightScore testing service for primary open-angle glaucoma
February 20th 2025

Seonix Bio launches SightScore testing service for primary open-angle glaucoma

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Envision Summit 2025: Advice on treating periorbital eye injuries
February 15th 2025

Envision Summit 2025: Advice on treating periorbital eye injuries

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

MediPrint Ophthalmics moves forward with LL-BMT1, sustained drug delivery contact lenses for glaucoma
February 15th 2025

MediPrint Ophthalmics moves forward with LL-BMT1, sustained drug delivery contact lenses for glaucoma

(Image credit: AdobeStock/Syda Productions)
February 12th 2025

Meibomian gland dysfunction in younger populations: why early detection is critical

© 2025 MJH Life Sciences

All rights reserved.